PolTREG S.A. (PTG) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.154x

Based on the latest financial reports, PolTREG S.A. (PTG) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-7.63 Million ≈ $-2.10 Million USD) by net assets (zł49.48 Million ≈ $13.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of PolTREG S.A. for the company's overall valuation and market capitalisation.

PolTREG S.A. - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how PolTREG S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

PolTREG S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PolTREG S.A. ranked by their cash flow conversion efficiency. Explore PTG operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
YSX Tech. Co., Ltd Class A Ordinary Shares
NASDAQ:YSXT
-0.250x
Ocean Vantage Holdings Bhd
KLSE:0220
-0.026x
Progressive Planet Solutions Inc
V:PLAN
0.088x
Perimeter Medical Imaging AI Inc
V:PINK
-0.343x
Electro-Sensors Inc
NASDAQ:ELSE
0.001x
BayWa Aktiengesellschaft
F:BYW
-0.099x
Sc Engineering
KO:023960
-0.308x
System1 Inc
NYSE:SST
-0.611x

Annual Cash Flow Conversion Efficiency for PolTREG S.A. (2018–2024)

The table below shows the annual cash flow conversion efficiency of PolTREG S.A. from 2018 to 2024. View PolTREG S.A. stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł69.23 Million
≈ $19.05 Million
zł-16.00 Million
≈ $-4.40 Million
-0.231x -52.30%
2023-12-31 zł87.52 Million
≈ $24.09 Million
zł-13.28 Million
≈ $-3.66 Million
-0.152x -78.29%
2022-12-31 zł101.04 Million
≈ $27.81 Million
zł-8.60 Million
≈ $-2.37 Million
-0.085x -128.55%
2021-12-31 zł103.01 Million
≈ $28.35 Million
zł-3.84 Million
≈ $-1.06 Million
-0.037x +82.85%
2020-12-31 zł12.83 Million
≈ $3.53 Million
zł-2.79 Million
≈ $-767.30K
-0.217x -100.11%
2019-12-31 zł-6.00K
≈ $-1.65K
zł-1.19 Million
≈ $-327.51K
198.333x +14627.96%
2018-12-31 zł764.00K
≈ $210.26K
zł-1.04 Million
≈ $-287.05K
-1.365x --

About PolTREG S.A.

WAR:PTG Poland Biotechnology
Market Cap
$26.95 Million
zł97.93 Million PLN
Market Cap Rank
#24213 Global
#234 in Poland
Share Price
zł21.00
Change (1 day)
+0.00%
52-Week Range
zł16.50 - zł29.00
All Time High
zł72.40
About

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.